{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:32:24Z","timestamp":1770748344677,"version":"3.50.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"UKaid"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.contraception.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T11:17:19Z","timestamp":1502968639000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study"],"prefix":"10.1016","volume":"97","author":[{"given":"Katharine","family":"Footman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahmida","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Dijkerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadid","family":"Nuremowla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2017.08.002_bb0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1057\/jphp.2012.11","article-title":"Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: a review of the literature","volume":"33","author":"Sneeringer","year":"2012","journal-title":"J Public Health Policy"},{"key":"10.1016\/j.contraception.2017.08.002_bb0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2012.10.020","article-title":"Misoprostol in women's hands: a harm reduction strategy for unsafe abortion","volume":"87","author":"Hyman","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.08.002_bb0015","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1471-0528.2005.00704.x","article-title":"Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association","volume":"112","author":"Miller","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2017.08.002_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2011.05.027","article-title":"New estimates and trends regarding unsafe abortion mortality","volume":"115","author":"\u00c5hman","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2017.08.002_bb0025","series-title":"Expanding health worker roles to help improve access to safe abortion and post-abortion care: WHO launches new guideline","author":"WHO","year":"2015"},{"key":"10.1016\/j.contraception.2017.08.002_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3126\/njog.v10i1.13188","article-title":"A study of complications following self-administration with medical abortion pills","volume":"10","author":"Giri","year":"2015","journal-title":"Nepal J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2017.08.002_bb0040","first-page":"QC01","article-title":"Is it safe to provide abortion pills over the counter? A study on outcome following self-medication with abortion pills","volume":"9","author":"Nivedita","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.contraception.2017.08.002_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2014.05.026","article-title":"Pharmacy recruitment of misoprostol users in Mexico: a feasibility study","volume":"90","author":"Brahmi","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.08.002_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-8080(04)24020-4","article-title":"A situation analysis of the menstrual regulation programme in Bangladesh","volume":"12","author":"Chowdhury","year":"2004","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2017.08.002_bb0055","series-title":"Menstrual regulation and postabortion care in Bangladesh: factors associated with access to and quality of services","author":"Vlassoff","year":"2012"},{"key":"10.1016\/j.contraception.2017.08.002_bb0060","series-title":"Minutes of 63rd meeting of the National Technical Meeting","author":"Government of the People's Republic of Bangladesh Directorate General of Family Planning","year":"2014"},{"key":"10.1016\/j.contraception.2017.08.002_bb0065","first-page":"1","article-title":"Factors contributing to the purchase of over the counter (OTC) drugs in Bangladesh: an empirical study","volume":"6","author":"Babu","year":"2007","journal-title":"Int J Third World Med"},{"key":"10.1016\/j.contraception.2017.08.002_bb0075","series-title":"Safe abortion: technical and policy guidance for health systems","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.contraception.2017.08.002_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijgo.2013.07.037","article-title":"Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey","volume":"124","author":"Huda","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2017.08.002_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijgo.2007.09.006","article-title":"Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy","volume":"99","author":"Fa\u00fandes","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2017.08.002_bb0090","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial","volume":"369","author":"Von Hertzen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2017.08.002_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone\u2013misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"Int J Gynecol Obstet"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417303980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417303980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T11:45:11Z","timestamp":1531136711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782417303980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0010782417303980"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2017.08.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}